Catalyst Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Catalyst Pharmaceuticals
CPRX Stock  USD 21.19  0.29  1.35%   
Catalyst Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Catalyst Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Catalyst Pharmaceuticals financial statements helps investors assess Catalyst Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Catalyst Pharmaceuticals' valuation are summarized below:
Gross Profit
160 M
Profit Margin
0.3101
Market Capitalization
2.6 B
Enterprise Value Revenue
4.6103
Revenue
460.5 M
We have found one hundred twenty available fundamental signals for Catalyst Pharmaceuticals, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Catalyst Pharmaceuticals prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road. Market Cap is likely to rise to about 1.9 B in 2024. Enterprise Value is likely to rise to about 1.7 B in 2024

Catalyst Pharmaceuticals Total Revenue

418.11 Million

Check Catalyst Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Catalyst Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 5 M, Other Operating Expenses of 327 M or Operating Income of 91.2 M, as well as many indicators such as Price To Sales Ratio of 4.26, Dividend Yield of 0.0 or PTB Ratio of 4.38. Catalyst financial statements analysis is a perfect complement when working with Catalyst Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Catalyst Pharmaceuticals Correlation against competitors.
For more information on how to buy Catalyst Stock please use our How to Invest in Catalyst Pharmaceuticals guide.

Catalyst Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets493.6 M470.1 M148.1 M
Slightly volatile
Total Stockholder Equity407.3 M387.9 M124.1 M
Slightly volatile
Cash144.5 M137.6 M73.8 M
Slightly volatile
Other Assets0.951.05 M
Slightly volatile
Cash And Short Term Investments144.5 M137.6 M88.5 M
Slightly volatile
Common Stock Shares Outstanding57 M113.8 M74.5 M
Slightly volatile
Liabilities And Stockholders Equity493.6 M470.1 M148.1 M
Slightly volatile
Other Stockholder Equity279.8 M266.5 M164.1 M
Slightly volatile
Total Liabilities86.3 M82.2 M24 M
Slightly volatile
Total Current Assets230.3 M219.3 M105.7 M
Slightly volatile
Other Current Liabilities63.2 M60.2 M15.3 M
Slightly volatile
Total Current Liabilities79.9 M76.1 M21.2 M
Slightly volatile
Property Plant And Equipment Net3.9 M3.7 M1.2 M
Slightly volatile
Accounts Payable15.5 M14.8 M3.8 M
Slightly volatile
Non Current Assets Total263.3 M250.8 M42.5 M
Slightly volatile
Common Stock Total Equity66.6 K120.8 K79.5 K
Slightly volatile
Property Plant And Equipment Gross4.6 M4.4 M1.3 M
Slightly volatile
Common Stock69.1 K107 K78.7 K
Slightly volatile
Property Plant Equipment1 M974 K547.4 K
Slightly volatile
Other Current Assets13.2 M12.5 M3.7 M
Slightly volatile
Net Receivables56.2 M53.5 M13.3 M
Slightly volatile
Other Liabilities17 M16.2 M6.5 M
Slightly volatile
Non Current Liabilities Total6.5 M6.2 M3.2 M
Slightly volatile
Net Tangible Assets323.5 M308.1 M111.3 M
Slightly volatile
Capital Surpluse169.1 M288 M161.5 M
Slightly volatile
Non Current Liabilities Other460.8 K485 K2.5 M
Slightly volatile
Net Invested Capital201.8 M387.9 M136.8 M
Slightly volatile
Net Working Capital147.7 M143.3 M110.3 M
Slightly volatile
Capital Stock114.6 K107 K104.1 K
Slightly volatile
Short and Long Term Debt Total2.6 M3.6 M1.4 M
Slightly volatile
Current Deferred Revenue623.3 K656.1 K15.9 M
Slightly volatile
Capital Lease Obligations2.7 M3.6 M1.6 M
Slightly volatile
Short Term Debt295.6 K369 K289.6 K
Very volatile

Catalyst Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses327 M311.4 M74.5 M
Slightly volatile
Research Development97.8 M93.2 M22.8 M
Slightly volatile
Total Operating Expenses272.4 M259.4 M61.6 M
Slightly volatile
Depreciation And Amortization34.8 M33.1 M4.7 M
Slightly volatile
Selling General Administrative49.4 M47 M17.2 M
Slightly volatile
Interest Income1.9 M1.8 M835.9 K
Slightly volatile
Net Interest Income1 M1.8 M877.9 K
Slightly volatile
Reconciled Depreciation25.6 M24.4 M3.5 M
Slightly volatile
Selling And Marketing Expenses91 M86.7 M19.3 M
Slightly volatile

Catalyst Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow313.3 M298.4 M76.2 M
Slightly volatile
Depreciation34.5 M32.9 M4.7 M
Slightly volatile
Capital Expenditures208.5 M198.5 M27.2 M
Slightly volatile
End Period Cash Flow144.5 M137.6 M73.8 M
Slightly volatile
Stock Based Compensation15 M14.2 M4.4 M
Slightly volatile
Net Borrowings4 M4.5 M4.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio4.264.4866215
Slightly volatile
PTB Ratio4.384.60625.1637
Slightly volatile
Days Sales Outstanding44.049.051838.9822
Slightly volatile
Book Value Per Share3.833.64961.2783
Slightly volatile
Average Payables4 M3.8 M2.5 M
Slightly volatile
Stock Based Compensation To Revenue0.0340.03583.8647
Slightly volatile
Capex To Depreciation6.346.03772.5341
Pretty Stable
PB Ratio4.384.60625.1637
Slightly volatile
EV To Sales3.944.1498196
Slightly volatile
Inventory Turnover5.135.4035215
Slightly volatile
Days Of Inventory On Hand56.0167.549132.2861
Slightly volatile
Payables Turnover3.425.71362.7992
Slightly volatile
Sales General And Administrative To Revenue0.110.118117.3039
Slightly volatile
Research And Ddevelopement To Revenue0.220.233921.6276
Slightly volatile
Capex To Revenue0.520.49850.167
Slightly volatile
Cash Per Share0.721.2950.9137
Slightly volatile
Days Payables Outstanding60.6963.88329.2 K
Slightly volatile
Income Quality2.112.01091.0823
Slightly volatile
Intangibles To Total Assets0.430.41280.1311
Slightly volatile
Current Ratio2.742.88358.8805
Slightly volatile
Tangible Book Value Per Share1.911.82381.0076
Slightly volatile
Receivables Turnover11.07.441111.4104
Slightly volatile
Graham Number7.87.4283.1793
Slightly volatile
Shareholders Equity Per Share3.833.64961.2783
Slightly volatile
Debt To Equity0.01280.00820.0096
Slightly volatile
Capex Per Share1.961.86790.2564
Slightly volatile
Graham Net Net0.620.97250.7649
Slightly volatile
Average Receivables7.8 M7.4 M5.5 M
Slightly volatile
Revenue Per Share3.933.74680.888
Slightly volatile
Interest Debt Per Share0.03150.030.0153
Slightly volatile
Debt To Assets0.01060.00680.0078
Slightly volatile
Operating Cycle74.6711742.8595
Slightly volatile
Price Book Value Ratio4.384.60625.1637
Slightly volatile
Days Of Payables Outstanding60.6963.88329.2 K
Slightly volatile
Ebt Per Ebit0.791.08870.9948
Very volatile
Company Equity Multiplier1.411.2121.3037
Slightly volatile
Long Term Debt To Capitalization0.01250.00820.0095
Slightly volatile
Total Debt To Capitalization0.01250.00820.0095
Slightly volatile
Debt Equity Ratio0.01280.00820.0096
Slightly volatile
Quick Ratio2.542.67788.8068
Slightly volatile
Net Income Per E B T1.110.75560.9826
Very volatile
Cash Ratio1.721.80954.5287
Very volatile
Days Of Inventory Outstanding56.0167.549132.2861
Slightly volatile
Days Of Sales Outstanding44.049.051838.9822
Slightly volatile
Cash Flow Coverage Ratios40.3345.043945.568
Slightly volatile
Price To Book Ratio4.384.60625.1637
Slightly volatile
Fixed Asset Turnover14110892.6365
Slightly volatile
Debt Ratio0.01060.00680.0078
Slightly volatile
Cash Flow To Debt Ratio40.3345.043945.568
Slightly volatile
Price Sales Ratio4.264.4866215
Slightly volatile
Asset Turnover0.890.8470.3053
Slightly volatile
Price Fair Value4.384.60625.1637
Slightly volatile

Catalyst Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.9 B1.8 B541.9 M
Slightly volatile
Enterprise Value1.7 B1.7 B466.4 M
Slightly volatile

Catalyst Fundamental Market Drivers

Forward Price Earnings10.7991
Cash And Short Term Investments137.6 M

Catalyst Upcoming Events

20th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Catalyst Pharmaceuticals Financial Statements

Catalyst Pharmaceuticals investors use historical fundamental indicators, such as Catalyst Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Catalyst Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue656.1 K623.3 K
Total Revenue398.2 M418.1 M
Cost Of Revenue84.5 M88.8 M
Stock Based Compensation To Revenue 0.04  0.03 
Sales General And Administrative To Revenue 0.12  0.11 
Research And Ddevelopement To Revenue 0.23  0.22 
Capex To Revenue 0.50  0.52 
Revenue Per Share 3.75  3.93 
Ebit Per Revenue 0.22  0.23 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
RSIRush Street Interactive
OKTAOkta Inc
BACBank of America

Additional Tools for Catalyst Stock Analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY